Kangmei Pharmaceutical is the famous Corporate Investor, which was founded in 1997. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Guangdong.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. The important activity for fund was in 2017.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Yichechuxing, Twist Bioscience Among the most popular fund investment industries, there are Health Care, Chemical. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Kangmei Pharmaceutical, startups are often financed by Asset Management Ventures (AMV), Paladin Capital Group, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Reinet Investments S.C.A., NFT Investment, FIS.
Fund Name | Location |
Arosa Capital Management | - |
Clarkston-Potomac | Durham, North Carolina, United States |
CP Holdings | Anhui, China, Macao |
Emerson Ventures | Canada, Ontario, Toronto |
First Partners Holding 5 | Norway, Oslo |
Georgia State University | Atlanta, Georgia, United States |
HMC Ventures | China, Hangzhou, Zhejiang |
INTCO Medical | China, Shandong, Zibo |
Kairos Angels | - |
Lumos Capital Group | California, San Francisco, United States |
Macomb Community College | Michigan, United States, Warren |
MassChallenge Switzerland | Renens, Switzerland, Vaud |
National Treasury Management Agency (NTMA) | County Dublin, Dublin, Ireland |
NIIF Ltd. | India, Maharashtra, Mumbai |
Oracle Investment Management Inc. | Connecticut, Greenwich, United States |
Steel City Capital Funding | - |
Sybat | France, Gennevilliers, Ile-de-France |
The Hina Group | California, San Francisco, United States |
Van Wickle Ventures | Providence, Rhode Island, United States |
Zhihe Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ZYBC | $1M | 31 Dec 2017 | Dongcheng District, Beijing, China | ||
Yichechuxing | $26M | 12 Dec 2017 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ZYBC | $1M | 31 Dec 2017 | Dongcheng District, Beijing, China | ||
Yichechuxing | $26M | 12 Dec 2017 | Futian District, Guangdong Province, China |